Abrysvo Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Resp syncytial virus (RSV) vaccine (bivalent, recombinant pre-fusion F protein)

Indications/Uses

Passive protection against lower resp tract disease caused by RSV in infants from birth through 6 mth following maternal immunisation. Active immunisation for prevention of lower resp tract disease caused by RSV in adults ≥60 yr.

Click to view Abrysvo detailed prescribing information

Dosage/Direction for Use

0.5 mL single dose IM inj. Pregnant individual Administer between 24 & 36 gestation wk.

Click to view Abrysvo detailed prescribing information

Overdosage

View Abrysvo overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Abrysvo detailed prescribing information

Special Precautions

Hypersensitivity & anaphylaxis. Postpone vaccination in individuals suffering from acute febrile illness. Thrombocytopenia or any coagulation disorder; anxiety-related reactions eg, vasovagal reactions (syncope), hyperventilation or stress-related reactions. Immunocompromised individuals including those receiving immunosuppressant therapy. Not to be mixed w/ any other vaccines or medicinal products. Pregnant individuals <24 gestation wk. Childn <18 yr.

Click to view Abrysvo detailed prescribing information

Use In Pregnancy & Lactation

Click to view Abrysvo detailed prescribing information

Adverse Reactions

Vaccination site pain. Vaccination site redness & swelling. Pregnant individuals ≤49 yr: Headache; myalgia.

Click to view Abrysvo detailed prescribing information

Drug Interactions

Min 2-wk interval recommended w/ tetanus, diphtheria & acellular pertussis (Tdap) vaccine administration.

Click to view Abrysvo detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Abrysvo detailed prescribing information

Storage

View Abrysvo storage conditions for details to ensure optimal shelf-life.

Description

View Abrysvo description for details of the chemical structure and excipients (inactive components).

Action

View Abrysvo mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.

Regulatory Classification

Presentation/Packing

Form

Abrysvo powd for inj (vial + solvent in pre-filled syringe) 120 mcg/0.5 mL

Packing/Price

1's

Abrysvo

respiratory syncytial virus vaccine

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma